Fluorinated indole-imidazole conjugates: Selective orally bioavailable 5-HT7 receptor low-basicity agonists, potential neuropathic painkillers
作者:Adam S. Hogendorf、Agata Hogendorf、Katarzyna Popiołek-Barczyk、Agata Ciechanowska、Joanna Mika、Grzegorz Satała、Maria Walczak、Gniewomir Latacz、Jadwiga Handzlik、Katarzyna Kieć-Kononowicz、Evgeni Ponimaskin、Sophie Schade、Andre Zeug、Monika Bijata、Maciej Kubicki、Rafał Kurczab、Tomasz Lenda、Jakub Staroń、Ryszard Bugno、Beata Duszyńska、Bogusław Pilarski、Andrzej J. Bojarski
DOI:10.1016/j.ejmech.2019.03.017
日期:2019.5
The 5-HT7 receptor has recently gained much attention due to its involvement in multiple physiological functions and diseases. The insufficient quality of the available molecular probes prompted design of fluorinated 3-(1-alkyl-1H-imidazol-5-yl)-1H-indoles as a new generation of selective 5-HT7 receptor agonists. A potent and drug-like agonist, 3-(1-ethyl-1H-imidazol-5-yl)-5-iodo-4-fluoro-1H-indole
5-HT 7受体由于其参与多种生理功能和疾病而最近引起了广泛关注。现有分子探针质量不足,促使设计了氟化3-(1-烷基-1 H-咪唑-5-基)-1 H-吲哚作为新一代的选择性5-HT 7受体激动剂。有效和药物样激动剂,3-(1-乙基-1- ħ咪唑-5-基)-5-碘-4-氟-1- ħ -吲哚(AGH-192,35,ķ I 5-HT 7 - [R = 4 nM),是通过以Ser5.42作为假定的配偶体优化卤素键形成来鉴定的。该化合物的特点是优异的水溶性,对相关中枢神经系统靶标的高选择性,高代谢稳定性,口服生物利用度和低细胞毒性。 在小鼠腹腔注射(2.5 mg / kg)后发现迅速吸收到血液中,半衰期中等,大脑中的最高峰浓度C max = 1069 ng / g。因此,AGH-192可能是研究5-HT 7受体功能以及潜在的镇痛剂的长期寻求的工具化合物,这在神经性疼痛小鼠模型中观察到的抗伤害感受作用表明。